NOX 0.00% 7.2¢ noxopharm limited

Ann: Further Review Shows Major Clinical Benefits from Veyonda, page-4

  1. 1,033 Posts.
    lightbulb Created with Sketch. 38
    This was announced a few weeks ago so no one is talking about it now. It actually was a good similar announcement last time but I was surprised how people didnt value this much. Surely this result would be grounds for at least a deal to be made with novartis. Obviously i cannot rule out a takeover offer. Maybe if they sort out their patent, it will be an option for big pharma.
    if they can duplicate the result in group 2, it could be a turning point for novartis to think about nox.

    btw, I am still waiting for the headline 'xx Patient(s) has been cured'.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.